Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Long-Term Outcomes and Health-Related Quality of Life (HRQoL) By Response Status for Bortezomib, Melphalan, and Prednisone (VMP) ± Daratumumab (DARA) in Alcyone

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-136145

Published: 2020

Journal Articles

Carfilzomib Thalidomide and Dexamethasone Is Safe and Effective in the Treatment of Relapsed/Refractory Multiple Myeloma: An Open Label Phase II Australasian Leukaemia and Lymphoma Group (ALLG) MM 018/ Asian Myeloma Network (AMN) 002 Study

Hang Quach, MD, Simon J Harrison, MBBS MRCP (UK) PhDFRCPath (UK) FRACP, Je-Jung Lee, MD PhD, Nichloas Murphy, MBBS, FRACP, FRCPA, Jae Hoon Lee, MD PhD, Kim Kihyun, MD, Jane Estell, FRACP, Noemi Horvath, MB ChB FRACP FRCPA, Richard Eek, FRACP., Bradley Augustson, MBBS FRACP FRCPA, Philip Campbell, MBBS, Rajeev Rajagopal, FRACP, Soo-Mee Bang, MDPhD, Jeffrey SY Huang, MD, PhD, Yoon Sung Soo, MD PhD, Belinda Butcher, BSci, MBiostat, PhD, Brian G.M. Durie, MD, Wee Joo Chng, MD PhD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-139174

Published: 2020

Journal Articles

Study of Treatment-Free Remission Evaluation in Real-World Chronic Myeloid Leukemia; Cost-Effectiveness Analysis

Bora Nam, MBA, PhD, Soktae Kim, MBA, PhD, Jae Hoon Lee, MD PhD, Kwai Han Yoo, MD, Jeong-Yeal Ahn, MD, Hawk Kim, MD PhD

Blood (2018) 132 (Supplement 1): 4261.

https://doi.org/10.1182/blood-2018-99-116422

Published: 2018

Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Blood (2018) 132 (Supplement 1): 5637.

https://doi.org/10.1182/blood-2018-99-116844

Published: 2018

Journal Articles

Evaluation of Clinical Usefulness of Monocyte Gating Using CD14 and CD64 for Detecting PNH Clone By Flow Cytometry

Woo Jae Kwoun, MD, Jeong-Yeal Ahn, MD, Ja Young Seo, MD, Jae Hoon Lee, MD PhD, Hawk Kim, MD PhD, Jinny Park, MD PhD, Kwai Han Yoo, MD, Sung-Ran Cho, MD, Hye Ryoun Kim, MD

Blood (2018) 132 (Supplement 1): 4947.

https://doi.org/10.1182/blood-2018-99-111468

Published: 2018

Journal Articles

Combined Analysis of 3,664 Patients with Multiple Myeloma (MM) from Latin America (LA) and Asia

Blood (2017) 130 (Supplement 1): 5386.

https://doi.org/10.1182/blood.V130.Suppl_1.5386.5386

Published: 2017

Journal Articles

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Juan Du, PhD MD, Weijun Fu, MD, Jae Hoon Lee, MD PhD, Chunyang Zhang, MD, Kihyun Kim, MD, Ai Jun Liu, MD, Jin Lu, Cheolwon Suh, MD PhD, Min Kyoung Kim, MD PhD, Wenming Chen, MD, Jin Liu, Hua Jiang, MD, Jian Hou, PhD MD

Blood (2017) 130 (Supplement 1): 5409.

https://doi.org/10.1182/blood.V130.Suppl_1.5409.5409

Published: 2017

Journal Articles

Bone Marrow Examination of Malignant Lymphomas in Korea: Eleven-Year Experience in a Single Institution

Woo Jae Kwoun, MD, Jeong-Yeal Ahn, MD, Ja Young Seo, MD, Jae Hoon Lee, MD PhD, Kwai Han Yoo, MD

Blood (2017) 130 (Supplement 1): 5147.

https://doi.org/10.1182/blood.V130.Suppl_1.5147.5147

Published: 2017

Journal Articles

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Jun Ho Jang, Jin Seok Kim, MD PhD, Deog-Yeon Jo, MD PhD, Je-Hwan Lee, MD PhD, Chul Won Choi, MD PhD, Hyeoung Joon Kim, MD PhD, Jong-Ho Won, MD PhD, Joo Seop Chung, MD PhD, Hawk Kim, MD PhD, Jae-Hoon Lee, MD PhD, Sang Kyun Sohn, MD PhD, Jeong A Kim, MD PhD, Jong Wook Lee, MD PhD

Blood (2015) 126 (23): 4789.

https://doi.org/10.1182/blood.V126.23.4789.4789

Published: 2015

Journal Articles

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Jong Wook Lee, MD PhD, Jun Ho Jang, MD PhD, Je-Hwan Lee, MD PhD, Deog-Yeon Jo, MD PhD, Jin Seok Kim, Yong Park, MD PhD, Sang Kyun Sohn, MD PhD, Jun Sung Park, MD PhD, Chul Won Choi, MD PhD, Joo Seop Chung, MD PhD, Jae Hoon Lee, MD PhD, Jeong A Kim, MD PhD, Jong-Ho Won, MD PhD

Blood (2014) 124 (21): 5151.

https://doi.org/10.1182/blood.V124.21.5151.5151

Published: 2014

Journal Articles

Efficacy of Treatments in Relapsed or Relapsed and Refractory Multiple Myeloma: An Indirect Treatment Comparison

Paul G. Richardson, Jae Hoon Lee, MD PhD, Istvan Majer, Arun Krishna, Richard C. Woodman, MD

Blood (2014) 124 (21): 2638.

https://doi.org/10.1182/blood.V124.21.2638.2638

Published: 2014

Journal Articles

Characterization of the Incidence and Management of Gastrointestinal Toxicity in the Phase 3 Panorama 1 Study of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

Blood (2014) 124 (21): 2120.

https://doi.org/10.1182/blood.V124.21.2120.2120

Published: 2014

Journal Articles

Concurrent Chemo-Radiotherapy Followed by VIDL (Etoposide, Ifosfamide, Dexamethasone, L-asparaginase) Chemotherapy In Stage I/II Extranodal NK/T-Cell Lymphoma of Nasal Cavity/Nasopharynx

Seok Jin Kim, MD, PhD, Hyeon-Seok Eom, Jin Seok Kim, Jae-Yong Kwak, Deok-Hwan Yang, Sung-Kyu Park, Jong Ho Won, Jae Hoon Lee, MD, PhD, Cheolwon Suh, MD, Won Seog Kim

Blood (2010) 116 (21): 1765.

https://doi.org/10.1182/blood.V116.21.1765.1765

Published: 2010

Journal Articles

Intensified 1st Cycle Rituximab (R) Plus 8 th Cycles of R-CHOP (cyclophosphamide, adriamycin, vincristine, prednisolone) Chemotherapy In Patients with Advanced or Bulky CD20 + Diffuse Large B-Cell Lymphoma (DLBCL); Open-Labelled, Multicenter Phase II CISL Study-Interim Analysis.

Jin Seok Kim, Won Seog Kim, Seok Jin Kim, MD, PhD, Hyeon Seok Eom, Deok-Hwan Yang, Yang Soo Kim, Hyo Jung Kim, Min Kyoung Kim, Suk-Joong Oh, Sung-Soo Yoon, Hun-Mo Ryoo, MD, PhD, Jae-Yong Kwak, Jae Hoon Lee, MD, PhD, Chul Won Choi, Hye Jin Kang, Yeung-Chul Mun, yun Deok Kim, Cheolwon Suh, MD

Blood (2010) 116 (21): 1786.

https://doi.org/10.1182/blood.V116.21.1786.1786

Published: 2010

Journal Articles

Matched Pair Analysis Comparing the Outcomes of Primary Breast and Nodal Diffuse Large B Cell Lymphoma In Patients Treated with R-Chop; Consortium for Improving Survival of Lymphoma (CISL) Study.

Ho-Young Yhim, Jae-Yong Kwak, Hye Jin Kang, Seok Jin Kim, MD, PhD, Won Seog Kim, Jin Seok Kim, Chul Won Choi, Hyeon Seok Eom, Jeong-A Kim, Jae Hoon Lee, MD, PhD, Jong Ho Won, Hyeok Shim, MD, Dae Ho Lee, Cheolwon Suh, MD

Blood (2010) 116 (21): 1790.

https://doi.org/10.1182/blood.V116.21.1790.1790

Published: 2010

Journal Articles

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Blood (2010) 116 (21): 1707.

https://doi.org/10.1182/blood.V116.21.1707.1707

Published: 2010

Journal Articles

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 mri.

Yoo-Hong Min, Hyeoung Joon Kim, MD, PhD, Kyoo-Hyung Lee, M.D., PhD., Jae Hoon Lee, MD, PhD, Hee-Sook Park, Jin Seok Kim, Hyeok Shim, MD, Chu-Myung Seung, Chul Soo Kim, Jooseop Chung, MD, PhD, Myung Soo Hyun, Deog-Yeon Jo, MD, PhD, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, MD, PhD, Byung Soo Kim, Young-Don Joo, Chi-Young Park

Blood (2010) 116 (21): 1125.

https://doi.org/10.1182/blood.V116.21.1125.1125

Published: 2010

Journal Articles

The Assessment of IL-6R Gene Using FISH in MM.

Hyun Jung Min, Tae Young Kim, MS, Bora Oh, MS, Jae Hoon Lee, MD, PhD, Dong Soon Lee, MD, PhD

Blood (2007) 110 (11): 4849.

https://doi.org/10.1182/blood.V110.11.4849.4849

Published: 2007

Journal Articles

(−)-Epigallocatechin-3-Gallate (EGCG), Green Tea Component, Antagonize the Anti-Myeloma Activity of Proteasome Inhibitor PS-341 by Direct Chemical Interaction.

Tae Young Kim, MS, Jongmin Park, BS, Bora Oh, MS, Hyun Jung Min, BS, Tae-Sook Jeong, PhD, Jae Hoon Lee, MD, PhD, Seung Bum Park, PhD, Dong Soon Lee, MD, PhD, the Korean Multiple Myeloma Working Party (KMMWP)

Blood (2007) 110 (11): 4850.

https://doi.org/10.1182/blood.V110.11.4850.4850

Published: 2007

NARROW

Long-Term Outcomes and Health-Related Quality of Life (HRQoL) By Response Status for Bortezomib, Melphalan, and Prednisone (VMP) ± Daratumumab (DARA) in Alcyone

Carfilzomib Thalidomide and Dexamethasone Is Safe and Effective in the Treatment of Relapsed/Refractory Multiple Myeloma: An Open Label Phase II Australasian Leukaemia and Lymphoma Group (ALLG) MM 018/ Asian Myeloma Network (AMN) 002 Study

Study of Treatment-Free Remission Evaluation in Real-World Chronic Myeloid Leukemia; Cost-Effectiveness Analysis

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Evaluation of Clinical Usefulness of Monocyte Gating Using CD14 and CD64 for Detecting PNH Clone By Flow Cytometry

Combined Analysis of 3,664 Patients with Multiple Myeloma (MM) from Latin America (LA) and Asia

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Bone Marrow Examination of Malignant Lymphomas in Korea: Eleven-Year Experience in a Single Institution

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Efficacy of Treatments in Relapsed or Relapsed and Refractory Multiple Myeloma: An Indirect Treatment Comparison

Characterization of the Incidence and Management of Gastrointestinal Toxicity in the Phase 3 Panorama 1 Study of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

Concurrent Chemo-Radiotherapy Followed by VIDL (Etoposide, Ifosfamide, Dexamethasone, L-asparaginase) Chemotherapy In Stage I/II Extranodal NK/T-Cell Lymphoma of Nasal Cavity/Nasopharynx

Intensified 1st Cycle Rituximab (R) Plus 8 th Cycles of R-CHOP (cyclophosphamide, adriamycin, vincristine, prednisolone) Chemotherapy In Patients with Advanced or Bulky CD20 + Diffuse Large B-Cell Lymphoma (DLBCL); Open-Labelled, Multicenter Phase II CISL Study-Interim Analysis.

Matched Pair Analysis Comparing the Outcomes of Primary Breast and Nodal Diffuse Large B Cell Lymphoma In Patients Treated with R-Chop; Consortium for Improving Survival of Lymphoma (CISL) Study.

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 mri.

The Assessment of IL-6R Gene Using FISH in MM.

(−)-Epigallocatechin-3-Gallate (EGCG), Green Tea Component, Antagonize the Anti-Myeloma Activity of Proteasome Inhibitor PS-341 by Direct Chemical Interaction.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only